Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism

Neuropeptides

Volumn 44, Issue 2, 2010, Pages 139-143

  Almeida, S S ^a   Barros, C C ^a   Moraes, M R ^a   Russo, F J ^a   Haro, A S ^a   Rosa, T S ^a   Alves, M F ^a   Pesquero, J B ^a   Carmona, A K ^a   Bacurau, R F P ^b   Araujo R C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sciences and Humanities USP   (Brazil)

Author keywords

Angiotensin I converting enzyme; Handgrip strength; I D polymorphism; Plasma kallikrein activity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; KALLIKREIN; KALLIKREIN INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GRIP STRENGTH; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENOTYPE; HAND STRENGTH; HEART RATE; HUMANS; INDEL MUTATION; MALE; PEPTIDYL-DIPEPTIDASE A; PLASMA KALLIKREIN; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 77049087281     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.12.003     Document Type: Article

References (41)

1. Alhenc-Gelas F., Richard J., Courbon D., Warnet J.M., and Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J. Lab. Clin. Med. 117 (1991) 33-39
2. Alvarez R., Terrados N., Ortolano R., Iglesias-Cubero G., Reguero J.R., Batalla A., Cortina A., Fernandez-Garcia B., Rodriguez C., Braga S., Alvarez V., and Coto E. Genetic variation in the renin-angiotensin system and athletic performance. Eur. J. Appl. Physiol. 82 (2000) 117-120
3. Alves M.F., Araujo M.C., Juliano M.A., Oliveira E.M., Krieger J.E., Casarini D.E., Juliano L., and Carmona A.K. A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz. J. Med. Biol. Res. 38 (2005) 861-868
4. Araujo M.C., Melo R.L., Cesari M.H., Juliano M.A., Juliano L., and Carmona A.K. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39 (2000) 8519-8525
5. Azizi M., Junot C., Ezan E., Hallouin M.C., Guyene T., and Menard J. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production. J. Mol. Med. 80 (2002) 492-498
6. Carmona A.K., Schwager S.L., Juliano M.A., Juliano L., and Sturrock E.D. A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay. Nat. Protoc. 1 (2006) 1971-1976
7. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., and Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92 (1995) 1387-1388
8. Dorer F.E., Kahn J.R., Lentz K.E., Levine M., and Skeggs L.T. Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ. Res. 34 (1974) 824-827
9. Ehlers M.R., Fox E.A., Strydom D.J., and Riordan J.F. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. USA 86 (1989) 7741-7745
10. Foschini, D., Araujo, R.C., Bacurau, R.F., De Piano, A., De Almeida, S.S., Carnier, J., Rosa, T.D., De Mello, M.T., Tufik, S., Damaso, A.R., 2009. Treatment of obese adolescents: the influence of periodization models and ACE genotype. Obesity (Silver Spring).
11. Henriques O.B., and Allan L. Glass activated kallikrein from human plasma. Biochem. Pharmacol. 21 (1972) 3163-3169
12. Jalil J.E., Cordova S., Ocaranza M., Schumacher E., Braun S., Chamorro G., Fardella C., and Lavandero S. Angiotensin I-converting enzyme insertion/deletion polymorphism and adrenergic response to exercise in hypertensive patients. Med. Sci. Monit. 8 (2002) CR566-571
13. Jalil J.E., Piddo A.M., Cordova S., Chamorro G., Braun S., Jalil R., Vega J., Jadue P.L., Lavandero S., and Lastra P. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population. Am. J. Hypertens. 12 (1999) 697-704
14. Jaspard E., Wei L., and Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II) Studies with bradykinin and other natural peptides. J. Biol. Chem. 268 (1993) 9496-9503
15. Jones A., and Woods D.R. Skeletal muscle RAS and exercise performance. Int. J. Biochem. Cell Biol. 35 (2003) 855-866
16. Kakoki M., and Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int. 75 (2009) 1019-1030
17. Lachurie M.L., Azizi M., Guyene T.T., Alhenc-Gelas F., and Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 91 (1995) 2933-2942
18. Lottenberg R., Christensen U., Jackson C.M., and Coleman P.L. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol. 80 Pt C (1981) 341-361
19. Montgomery H., Clarkson P., Barnard M., Bell J., Brynes A., Dollery C., Hajnal J., Hemingway H., Mercer D., Jarman P., Marshall R., Prasad K., Rayson M., Saeed N., Talmud P., Thomas L., Jubb M., World M., and Humphries S. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353 (1999) 541-545
20. Moraes M.R., Bacurau R.F., Ramalho J.D., Reis F.C., Casarini D.E., Chagas J.R., Oliveira V., Higa E.M., Abdalla D.S., Pesquero J.L., Pesquero J.B., and Araujo R.C. Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers. Biol. Chem. 388 (2007) 533-540
21. Murphey L.J., Gainer J.V., Vaughan D.E., and Brown N.J. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 102 (2000) 829-832
22. Myerson S., Hemingway H., Budget R., Martin J., Humphries S., and Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol. 87 (1999) 1313-1316
23. O'Donnell C.J., Lindpaintner K., Larson M.G., Rao V.S., Ordovas J.M., Schaefer E.J., Myers R.H., and Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
24. Okada Y., Tsuda Y., Tada M., Wanaka K., Hijikata-Okunomiya A., Okamoto U., and Okamoto S. Development of plasma kallikrein selective inhibitors. Biopolymers 51 (1999) 41-50
25. Omran S., Hallouda M., Essawi F., el Attar I., Aboul Enein A., Gaafar T., and Afifi N. Effect of cold storage on the haemostatic cascade systems. Transfus. Sci. 17 (1996) 407-414
26. Pontes Jr. F.L., Bacurau R.F., Moraes M.R., Navarro F., Casarini D.E., Pesquero J.L., Pesquero J.B., Araujo R.C., and Picarro I.C. Kallikrein -kinin system activation in post-exercise hypotension in water running of hypertensive volunteers. Int. Immunopharmacol. 8 (2008) 261-266
27. Rankinen T., Wolfarth B., Simoneau J.A., Maier-Lenz D., Rauramaa R., Rivera M.A., Boulay M.R., Chagnon Y.C., Perusse L., Keul J., and Bouchard C. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J. Appl. Physiol. 88 (2000) 1571-1575
28. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
29. Rousseau A., Michaud A., Chauvet M.T., Lenfant M., and Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270 (1995) 3656-3661
30. Shanmugam V., Sell K.W., and Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3 (1993) 120-121
31. Thomis M.A., Huygens W., Heuninckx S., Chagnon M., Maes H.H., Claessens A.L., Vlietinck R., Bouchard C., and Beunen G.P. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur. J. Appl. Physiol. 92 (2004) 267-274
32. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., and Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51 (1992) 197-205
33. Topouchian J.A., El Assaad M.A., Orobinskaia L.V., El Feghali R.N., and Asmar R.G. Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press. Monit. 10 (2005) 325-331
34. van der Meer P., Lipsic E., Westenbrink B.D., van de Wal R.M., Schoemaker R.G., Vellenga E., van Veldhuisen D.J., Voors A.A., and van Gilst W.H. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112 (2005) 1743-1747
35. van Esch J.H., van Gool J.M., de Bruin R.J., Payne J.R., Montgomery H.E., Hectors M., Deinum J., Dive V., and Jan Danser A.H. Different contributions of the angiotensin-converting enzyme C- and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype. J. Hypertens. 26 (2008) 706-713
36. Wanaka K., Okamoto S., Bohgaki M., Hijikata-Okunomiya A., Naito T., and Okada Y. Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis. Thromb. Res. 57 (1990) 889-895
37. Wei L., Alhenc-Gelas F., Corvol P., and Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266 (1991) 9002-9008
38. Wei L., Clauser E., Alhenc-Gelas F., and Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267 (1992) 13398-13405
39. Williams A.G., Day S.H., Folland J.P., Gohlke P., Dhamrait S., and Montgomery H.E. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med. Sci. Sports Exerc. 37 (2005) 944-948
40. Yang H.Y., Erdos E.G., and Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta 214 (1970) 374-376
41. Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H., Easteal S., and North K. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73 (2003) 627-631